Prothena Corp PLC (PRTA)
19.87
-0.69
(-3.36%)
USD |
NASDAQ |
Apr 25, 10:13
Prothena Enterprise Value: 485.66M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 485.66M |
| April 23, 2024 | 485.66M |
| April 22, 2024 | 524.88M |
| April 19, 2024 | 517.90M |
| April 18, 2024 | 486.20M |
| April 17, 2024 | 509.30M |
| April 16, 2024 | 527.57M |
| April 15, 2024 | 562.48M |
| April 12, 2024 | 575.91M |
| April 11, 2024 | 631.78M |
| April 10, 2024 | 607.07M |
| April 09, 2024 | 645.75M |
| April 08, 2024 | 653.27M |
| April 05, 2024 | 636.62M |
| April 04, 2024 | 630.71M |
| April 03, 2024 | 684.43M |
| April 02, 2024 | 667.78M |
| April 01, 2024 | 785.96M |
| March 28, 2024 | 711.83M |
| March 27, 2024 | 732.78M |
| March 26, 2024 | 710.75M |
| March 25, 2024 | 745.67M |
| March 22, 2024 | 773.61M |
| March 21, 2024 | 755.88M |
| March 20, 2024 | 751.58M |
| Date | Value |
|---|---|
| March 19, 2024 | 729.02M |
| March 18, 2024 | 729.02M |
| March 15, 2024 | 781.66M |
| March 14, 2024 | 803.69M |
| March 13, 2024 | 917.58M |
| March 12, 2024 | 860.63M |
| March 11, 2024 | 888.57M |
| March 08, 2024 | 1.005B |
| March 07, 2024 | 955.18M |
| March 06, 2024 | 957.33M |
| March 05, 2024 | 904.15M |
| March 04, 2024 | 902.53M |
| March 01, 2024 | 913.82M |
| February 29, 2024 | 863.32M |
| February 28, 2024 | 937.99M |
| February 27, 2024 | 1.009B |
| February 26, 2024 | 895.01M |
| February 23, 2024 | 843.44M |
| February 22, 2024 | 828.94M |
| February 21, 2024 | 834.31M |
| February 20, 2024 | 860.10M |
| February 16, 2024 | 886.42M |
| February 15, 2024 | 913.28M |
| February 14, 2024 | 846.64M |
| February 13, 2024 | 803.68M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-123.26M
Minimum
Aug 23 2019
3.460B
Maximum
May 05 2023
1.071B
Average
869.33M
Median
Sep 14 2022
Enterprise Value Benchmarks
| Amarin Corp PLC | 31.97M |
| Jazz Pharmaceuticals PLC | 10.84B |
| Iterum Therapeutics PLC | 20.49M |
| GH Research PLC | 414.91M |
| Mural Oncology PLC | -209.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -67.48M |
| Revenue (Quarterly) | 0.316M |
| Total Expenses (Quarterly) | 78.83M |
| EPS Diluted (Quarterly) | -1.26 |
| Profit Margin (Quarterly) | -21.35K% |
| Earnings Yield | -14.09% |
| Normalized Earnings Yield | -14.09 |